NovoCure Ltd reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
St. Helier
SEC filing record 1 source field available
Fiscal year end
31 December
NovoCure Ltd has filed 1,164 SEC EDGAR filings since 24 Jun 2015

SEC filing history

Showing 901-925 of 1,000 matching filings.

Per page
25
Current page
37
4

FORM 4 SUBMISSION

Filing date
05 Apr 2018
Reporting date
04 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37565

8-K - 2015 PLAN FORMS FOR ISRAEL AND GERMANY

Filing date
04 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Apr 2018
Reporting date
02 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2018
Reporting date
19 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2018
Reporting date
27 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37565

8-K

Filing date
22 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89354

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89354

SC 13G filing

Filing date
09 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Feb 2018
Reporting date
06 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37565

8-K -2018 BIOPHARMA - MATERIAL DEFINITIVE AGREEMENT

Filing date
08 Feb 2018
Reporting date
07 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89354

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
02 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2018
Reporting date
29 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2018
Reporting date
29 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .